Skip to main content

CHE

Stock

CHE

Stock
Health Care
Medical Care Facilities

Performance overview

CHE Price
Price Chart

Forward-looking statistics

Beta
0.53
Risk
24.91%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.

Company info

SectorHealth Care
IndustryMedical Care Facilities
Employees8K
Market cap$8.2B

Fundamentals

Enterprise value$7.1B
Revenue$2.5B
Revenue per employee—
Profit margin12.40%
Debt to equity12.28

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$20.49
Dividend per share$2.00
Revenue per share$167.06
Avg trading volume (30 day)$74M
Avg trading volume (10 day)$118M
Put-call ratio—

Macro factor sensitivity

Growth-1.1
Credit+3.5
Liquidity+0.8
Inflation-3.2
Commodities-0.1
Interest Rates-0.9

Valuation

Dividend yield0.42%
PEG Ratio19.01
Price to sales2.78
P/E Ratio19.01
Enterprise Value to Revenue2.84
Price to book5.84

Upcoming events

Next earnings dayApril 24, 2025
Next dividend day—
Ex. dividend dayMay 29, 2025

News

ASTH or CHE: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research (July 10, 2025)
Final Trades: Exxon, Chemed, Las Vegas Sands and the IEO

The Investment Committee give you their top stocks to watch for the second half.

CNBC Television (October 1, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free